Rentabilidad en 3 años
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 3 años | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 921 a 930 de un total de 43666 fondos | ||||||
| TEMPLETON EMERGING MARKETS A (ACC) USD | 16/09 | 88,79% | ||||
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | 16/09 | 88,78% | ||||
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I EUR | 16/09 | 88,78% | ||||
| TEMPLETON EMERGING MARKETS A (ACC) HKD | 16/09 | 88,77% | ||||
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | 16/09 | 88,76% | ||||
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | 16/09 | 88,76% | ||||
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A EUR ACC | 16/09 | 88,74% | ||||
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I USD | 16/09 | 88,66% | ||||
| BRIGHTGATE FOCUS, FI A | 11/09 | 88,62% | ||||
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | 16/09 | 88,61% | ||||
